WO2013138324A2 - Improved sterilization method - Google Patents

Improved sterilization method Download PDF

Info

Publication number
WO2013138324A2
WO2013138324A2 PCT/US2013/030487 US2013030487W WO2013138324A2 WO 2013138324 A2 WO2013138324 A2 WO 2013138324A2 US 2013030487 W US2013030487 W US 2013030487W WO 2013138324 A2 WO2013138324 A2 WO 2013138324A2
Authority
WO
WIPO (PCT)
Prior art keywords
acid
stabilizer
peracetic acid
gaseous stream
peracetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2013/030487
Other languages
French (fr)
Other versions
WO2013138324A3 (en
Inventor
John M. Rovison
Ricky MITTIGA
Donald LAPHAM
Weidong An
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP13761522.5A priority Critical patent/EP2825212B1/en
Priority to CN201380024885.2A priority patent/CN104284683B/en
Priority to AU2013232279A priority patent/AU2013232279A1/en
Priority to BR112014022845-0A priority patent/BR112014022845B1/en
Priority to KR1020147028636A priority patent/KR20150080448A/en
Priority to ES13761522.5T priority patent/ES2662502T3/en
Priority to JP2015500513A priority patent/JP6286413B2/en
Priority to MX2014011086A priority patent/MX358555B/en
Application filed by FMC Corp filed Critical FMC Corp
Priority to PL13761522T priority patent/PL2825212T3/en
Priority to DK13761522.5T priority patent/DK2825212T3/en
Publication of WO2013138324A2 publication Critical patent/WO2013138324A2/en
Publication of WO2013138324A3 publication Critical patent/WO2013138324A3/en
Anticipated expiration legal-status Critical
Priority to AU2015264881A priority patent/AU2015264881B2/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/16Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/22Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients stabilising the active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/20Gaseous substances, e.g. vapours
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/15Laboratory, medical or dentistry appliances, e.g. catheters or sharps
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00Gas and liquid contact apparatus
    • Y10S261/17Odorizers

Definitions

  • the present invention is directed to a method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized.
  • a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid
  • c) contacting such peracetic acid vapor with the material to be sterilized The use of
  • PAA peracetic acid
  • stabilizers are typically added. These stabilizers act as chelators for dissolved metal cations that can disrupt the peroxide bond.
  • PAA compositions comprising citric acid have been disclosed in the past, such compositions have been employed in liquid aqueous sanitizing applications only.
  • WO 2008/079999 discloses sterilizing compositions comprised of PAA, citric acid or a salt thereof, and salicylic acid or a salt thereof, which compositions are applied topically to the surfaces to be disinfected employing solution spray systems or the like.
  • US Patent 6,117,457 and European Patent Application 720814 both disclose the use of citric acid in aqueous PAA generation systems; either as a pH regulator in fish ponds or as a means of providing extended PAA generation, respectively.
  • the present invention is directed to a method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized.
  • This method permits the effective vapor sterilization of a material without the need for frequently disassembling the apparatus employed in order to remove the buildup of residue which occurs upon the heating surfaces of such apparatus.
  • the present invention is directed to a method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized.
  • vapor means a state in which the peracetic acid is substantially entirely in the gaseous form. This is in contrast to mist or fog, both of which contain a significant proportion of liquid droplets suspended in the air. Unlike the use of a mist or fog, it has been found that the use of peracetic acid in vapor form provides excellent sterilization of materials without the concomitant formation of water droplets on the material surface.
  • Peracetic acid is typically employed in the form of an aqueous equilibrium mixture of acetic acid, hydrogen peroxide and peracetic acid.
  • the weight ratios of these components may vary greatly, depending upon the particular grade of PAA employed.
  • grades of PAA which may be employed are those having weight ratios of PAA:hydrogen peroxide: acetic acid of from 12-18:21-24:5-20; 15:10:36; 5:23:10; and 35:10:15.
  • the stabilizer employed in the PAA sterilizing composition is selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-1,2,3- tricarboxylic acid.
  • such stabilizer is citric acid.
  • the stabilizer is employed in an amount sufficient to stabilize the PAA for at least three months.
  • the stabilizer is present at a concentration sufficient to stabilize the PAA for a period of at least six months.
  • such stabilizer will typically be present in an amount of between about 0.75% and about 1.5%; preferably of between about 0.9% and 1.25%; and more preferably of between about 1.0% and about 1.2% ; all such percentages being by weight, based upon the total weight of the PAA composition.
  • composition employed in the process of this invention may further comprise sequestriants such as dipicolinic acid, as well as other ingredients such as mineral acid catalysts (sulfuric, nitric, or phosphoric acids); surfactants such as anionic laurylates, sorbitans and their respective esters, i.e. polyethylene sorbitan monolaurylates; and short chain fatty esters (C6-C12) forming mixed peracids in solution.
  • sequestriants such as dipicolinic acid, as well as other ingredients such as mineral acid catalysts (sulfuric, nitric, or phosphoric acids); surfactants such as anionic laurylates, sorbitans and their respective esters, i.e. polyethylene sorbitan monolaurylates; and short chain fatty esters (C6-C12) forming mixed peracids in solution.
  • sequestriants such as dipicolinic acid, as well as other ingredients such as mineral acid catalysts (sulfuric, nitric
  • compositions employed in the process of this invention may further comprise one or more additional oxidants selected from the group consisting of chloroperbenzoic acid, perheptanoic acid, peroctanoic acid, perdecanoic acid, performic acid, percitric acid, perglycolic acid, perlactic acid and perbenzoic acid.
  • additional oxidants selected from the group consisting of chloroperbenzoic acid, perheptanoic acid, peroctanoic acid, perdecanoic acid, performic acid, percitric acid, perglycolic acid, perlactic acid and perbenzoic acid.
  • the peracetic acid sterilizing composition is preferably diluted, prior to its introduction into the heated gas stream, by the addition of high quality water (deionized water with >2 MOhm resistivity or ⁇ 0.5 ⁇ 8 ⁇ 6 ⁇ 6 ⁇ 8 conductivity), to a concentration of less than about 10,000 parts per million (ppm) of PAA, preferably to a concentration of less than about 4,000 ppm PAA.
  • high quality water deionized water with >2 MOhm resistivity or ⁇ 0.5 ⁇ 8 ⁇ 6 ⁇ 6 ⁇ 8 conductivity
  • the heated gas stream is typically sterile air, although other gases such as nitrogen, C0 2 , or inert noble gas carriers may also be employed.
  • Such gas stream is typically heated to a temperature of at least about 300° C, preferably to a minimal temperature of about 250° C and can be in excess of 350° C providing it can be cooled sufficiently for application. It then is typically cooled to between about 80° C and about 120° C prior to the introduction of the peracetic acid solution.
  • the heated gas stream at the point of peracetic acid introduction should have a temperature of at least 5° C higher than the dew point of peracetic acid (ca. 46.5°-49.9°C); i.e., of at least about 55° C, in order to ensure that the peracetic acid is converted into a vapor rather than a fog or mist.
  • the peracetic acid may be introduced into the heated air stream by any means well known to one of skill in the art.
  • One preferred method is by direct injection of a solution.
  • the peracetic acid vapor is then contacted with the material to be sterilized for a period sufficient to kill the contaminants of concern.
  • This time period will vary according to variables such as the concentration of the peracetic acid vapor employed; the nature of the surface of the material to be sterilized; the particular contaminants to be sterilized; the concentration of the contaminants to be sterilized; and the like. Typically, such contact will maintained for a period of between about 15 and about 40 minutes.
  • a wide variety of materials may be sterilized employing the method of this invention, including hard surfaces of metals, plastics, polymers, and elastomers.
  • the present method may be used to sterilize materials contaminated with those bacteria typically controlled by peracetic acid in the liquid form.
  • bacteria typically controlled by peracetic acid in the liquid form.
  • These include bacteria and spores of the genus Bacillus using B. thuringiensis and B. atrophaeus as surrogates for more pathogenic species (forms) such as C. botulinum as well as more typical genera of bacteria, fungi, and viruses and protozoans often controlled by PAA such as (but not limited to): Staphlococcus, Enterococcus, Salmonella, Campylobacter, Pseudomonas, Candida, Rhizopus, Mucor, Influenza, Bacilli, etc.
  • Sample Bl 4000 ppm PAA + about 24 ppm Dequest 2010
  • the PAA employed had a PAA:hydrogen peroxide: acetic acid weight ratio of about 15:10:36.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Inorganic Chemistry (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Detergent Compositions (AREA)

Abstract

A method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane- 1,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized. The use of such an organic acid stabilizer results in an unexpected reduction in the amount of residue deposited on the heating surface employed to vaporize the sterilizing composition.

Description

IMPROVED STERILIZATION METHOD
Field of the Invention
[0001] The present invention is directed to a method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized. The use of such an organic acid stabilizer results in an unexpected reduction in the amount of residue deposited on the heating surface employed to vaporize the sterilizing mixture.
Background of the Invention
[0002] The necessity of sterilizing surfaces for health and sanitary purposes has long been recognized. Effective sterilization processes are needed for a variety of purposes including aseptic packaging, medical instrument sterilization, biocidal vector environmental remediation, fumigation, vessel sterilization, food stuff treatments, and others.
[0003] Among the compounds employed as a sterilizer for such uses is peracetic acid ("PAA"), also called peroxyacetic acid. In order to prolong the shelf-life of PAA compositions, stabilizers are typically added. These stabilizers act as chelators for dissolved metal cations that can disrupt the peroxide bond.
[0004] The use of vapor phase peracetic acid to sterilize surfaces is described in US Patent Application 2010/0196197. This publication discloses the use of peracetic acid stabilized with phosphonic acid or acid stabilizers such as Dequest 2010, 1- Hydroxyethylidene -1,1,-diphosphonic acid. While such process is effective to sterilize a variety of different surfaces, it has been found that when such phosphonic acid stabilizers are employed the surface of the heating element used to vaporize the peracetic acid solution tends to become covered with residue over a period of time. This build-up of residue requires that such surface be periodically cleaned, a process which can be time consuming and expensive.
[0005] It would therefore be highly desirable to possess a method for using vapor phase peroxyacetic acid as a sterilizing agent which method did not require the relatively frequent cleaning of the heating surfaces of the equipment employed.
[0006] While PAA compositions comprising citric acid have been disclosed in the past, such compositions have been employed in liquid aqueous sanitizing applications only. Thus, for example, WO 2008/079999 discloses sterilizing compositions comprised of PAA, citric acid or a salt thereof, and salicylic acid or a salt thereof, which compositions are applied topically to the surfaces to be disinfected employing solution spray systems or the like. Somewhat similarly, US Patent 6,117,457 and European Patent Application 720814 both disclose the use of citric acid in aqueous PAA generation systems; either as a pH regulator in fish ponds or as a means of providing extended PAA generation, respectively.
[0007] However, it has now been unexpectedly found that when PAA stabilized with an organic acid such as citric acid is employed in vapor phase sterilization, the buildup of residue on heating surfaces is considerably less than when a phosphonic acid stabilizer is employed. This result is particularly unexpected in view of the showing that aqueous solutions of citric acid (in the absence of PAA) result in the undesirable buildup of residue on heating surfaces.
Summary of the Invention
[0008] The present invention is directed to a method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized.
[0009] This method permits the effective vapor sterilization of a material without the need for frequently disassembling the apparatus employed in order to remove the buildup of residue which occurs upon the heating surfaces of such apparatus.
Accordingly, a wide variety of materials may be rapidly and economically sterilized employing the method of this invention.
Detailed Description of the Invention
[0010] The present invention is directed to a method of sterilizing a material, said method comprising the steps of: a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-l,2,3-tricarboxylic acid; b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and c) contacting such peracetic acid vapor with the material to be sterilized.
[0011] As is employed herein, the term vapor means a state in which the peracetic acid is substantially entirely in the gaseous form. This is in contrast to mist or fog, both of which contain a significant proportion of liquid droplets suspended in the air. Unlike the use of a mist or fog, it has been found that the use of peracetic acid in vapor form provides excellent sterilization of materials without the concomitant formation of water droplets on the material surface.
[0012] Peracetic acid is typically employed in the form of an aqueous equilibrium mixture of acetic acid, hydrogen peroxide and peracetic acid. The weight ratios of these components may vary greatly, depending upon the particular grade of PAA employed. Among the grades of PAA which may be employed are those having weight ratios of PAA:hydrogen peroxide: acetic acid of from 12-18:21-24:5-20; 15:10:36; 5:23:10; and 35:10:15.
[0013] The stabilizer employed in the PAA sterilizing composition is selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane-1,2,3- tricarboxylic acid. Preferably, such stabilizer is citric acid.
[0014] Typically, the stabilizer is employed in an amount sufficient to stabilize the PAA for at least three months. Preferably, the stabilizer is present at a concentration sufficient to stabilize the PAA for a period of at least six months.
[0015] In general, such stabilizer will typically be present in an amount of between about 0.75% and about 1.5%; preferably of between about 0.9% and 1.25%; and more preferably of between about 1.0% and about 1.2% ; all such percentages being by weight, based upon the total weight of the PAA composition.
[0016] The composition employed in the process of this invention may further comprise sequestriants such as dipicolinic acid, as well as other ingredients such as mineral acid catalysts (sulfuric, nitric, or phosphoric acids); surfactants such as anionic laurylates, sorbitans and their respective esters, i.e. polyethylene sorbitan monolaurylates; and short chain fatty esters (C6-C12) forming mixed peracids in solution.
[0017] In addition, the compositions employed in the process of this invention may further comprise one or more additional oxidants selected from the group consisting of chloroperbenzoic acid, perheptanoic acid, peroctanoic acid, perdecanoic acid, performic acid, percitric acid, perglycolic acid, perlactic acid and perbenzoic acid.
[0018] In the practice of the process of this invention, the peracetic acid sterilizing composition is preferably diluted, prior to its introduction into the heated gas stream, by the addition of high quality water (deionized water with >2 MOhm resistivity or <0.5 μ8ΐ6ηΐ6η8 conductivity), to a concentration of less than about 10,000 parts per million (ppm) of PAA, preferably to a concentration of less than about 4,000 ppm PAA.
[0019] The heated gas stream is typically sterile air, although other gases such as nitrogen, C02, or inert noble gas carriers may also be employed. Such gas stream is typically heated to a temperature of at least about 300° C, preferably to a minimal temperature of about 250° C and can be in excess of 350° C providing it can be cooled sufficiently for application. It then is typically cooled to between about 80° C and about 120° C prior to the introduction of the peracetic acid solution. The heated gas stream at the point of peracetic acid introduction should have a temperature of at least 5° C higher than the dew point of peracetic acid (ca. 46.5°-49.9°C); i.e., of at least about 55° C, in order to ensure that the peracetic acid is converted into a vapor rather than a fog or mist.
[0020] The peracetic acid may be introduced into the heated air stream by any means well known to one of skill in the art. One preferred method is by direct injection of a solution.
[0021] The peracetic acid vapor is then contacted with the material to be sterilized for a period sufficient to kill the contaminants of concern. This time period will vary according to variables such as the concentration of the peracetic acid vapor employed; the nature of the surface of the material to be sterilized; the particular contaminants to be sterilized; the concentration of the contaminants to be sterilized; and the like. Typically, such contact will maintained for a period of between about 15 and about 40 minutes.
[0022] A wide variety of materials may be sterilized employing the method of this invention, including hard surfaces of metals, plastics, polymers, and elastomers.
[0023] The present method may be used to sterilize materials contaminated with those bacteria typically controlled by peracetic acid in the liquid form. These include bacteria and spores of the genus Bacillus using B. thuringiensis and B. atrophaeus as surrogates for more pathogenic species (forms) such as C. botulinum as well as more typical genera of bacteria, fungi, and viruses and protozoans often controlled by PAA such as (but not limited to): Staphlococcus, Enterococcus, Salmonella, Campylobacter, Pseudomonas, Candida, Rhizopus, Mucor, Influenza, Bacilli, etc.
[0024] The following Examples are presented to offer further illustration of the present invention, but are not intended to limit the scope of the invention in any manner whatsoever.
Example 1
[0025] In order to demonstrate the stabilizing effect of citric acid on PAA compositions, varying amounts of citric acid were added to concentrated PAA compositions, which compositions were stored at room temperature. Periodically, at the times indicated in Tables 1-4 below, samples of such compositions were analyzed for their peracetic acid (PAA); hydrogen peroxide (H2O2); and acetic acid (AA) contents (in percent by weight); and their Active Oxygen Recovery percentage (AO Rec) was calculated. The data presented in such Tables indicates that citric acid alone can stabilize PAA compositions for extended periods of more than 3 or 6 months.
Table 1:0.91% Citric Acid
Figure imgf000008_0001
Table 2: 1.00% Citric Acid
Figure imgf000009_0001
Table 3: 1.15% Citric Acid
Figure imgf000010_0001
Table 4: 1.24% Citric Acid
Figure imgf000011_0001
Example 2
[0026] In order to determine the amount of residue buildup produced by
vaporization, various solutions were prepared by blending the following ingredients:
Samples Al, A2 and A3: 250 ppm citric acid in deionized water
Sample Bl: 4000 ppm PAA + about 24 ppm Dequest 2010
Samples CI and C2: 4000 ppm PAA + 250 ppm citric acid
[0027] The PAA employed had a PAA:hydrogen peroxide: acetic acid weight ratio of about 15:10:36.
[0028] An initial portion of the sample to be tested was placed into a 50 mL burette suspended over a 100 mL beaker placed on a Corning Stirrer/Hotplate. The hotplate was heated to 180° C and the stopcock on the burette opened such that the solution was added drop wise for vaporization. The burette was refilled before it ran out of solution. The hotplate was shut off and the beaker allowed to return to room temperature. Once it had cooled to room temperature, the beaker was reweighed to determine the amount of residue present. The results observed and the calculated amount of residue (mg/mL) are summarized in Table 5 below.
Table 5
Figure imgf000012_0001
[0029] The above results show that the method of the present invention (exemplified in Samples CI and C2) produces considerably less residue of the heating surface than does a PAA composition of equal concentration which is stabilized using a phosphonate stabilizer. This result is completely unexpected in view of the showing that the vaporization of citric acid in deionized water results in the formation of a much more residue than does the vaporization of a composition comprising an equal amount of citric acid in a PAA solution.

Claims

What is claimed is:
1. A method of sterilizing a material, said method comprising the steps of:
a) providing a sterilizing composition comprising (i) peracetic acid and (ii) a stabilizer selected from the group consisting of citric acid, isocitric acid, aconitic acid and propane- 1,2,3- tricarboxylic acid;
b) introducing such sterilizing composition into a hot gaseous stream to produce a peracetic acid vapor; and
b) contacting such peracetic acid vapor with the material to be sterilized.
2. The method of claim 1 wherein the peracetic acid is present in a concentration of from about 15 to about 17 weight percent of the sterilizing composition; and the stabilizer is present in an amount between about 0.75 and about 1.5 weight percent of the sterilizing composition.
3. The method of claim 2 wherein the stabilizer is present in an amount between about 0.9 and about 1.25 weight percent of the sterilizing composition.
4. The method of claim 3 wherein the stabilizer is present in an amount between about 1.0 and about 1.2 weight percent of the sterilizing composition.
5. The method of claim 1 wherein the stabilizer is citric acid.
6. The method of claim 2 wherein the stabilizer is citric acid.
7. The method of claim 3 wherein the stabilizer is citric acid.
8. The method of claim 4 wherein the stabilizer is citric acid.
9. The method of claim 1 wherein the material is selected from the group consisting of metals, plastics, polymers and elastomers.
10. The method of claim 1 wherein the peracetic acid is diluted to a concentration of less than 10,000 ppm prior to being introduced into the hot gaseous stream.
11. The method of claim 10 wherein the peracetic acid is diluted to a concentration of less than 4,000 ppm prior to being introduced into the hot gaseous stream.
12. The method of claim 1 wherein the hot gaseous stream is sterile air.
13. The method of claim 1 wherein the hot gaseous stream is selected from the group consisting of nitrogen, carbon dioxide and noble gases.
14. The method of claim 1 wherein the hot gaseous stream is heated to a temperature above about 250° C prior to the introduction of the peracetic acid.
15. The method of claim 1 wherein the hot gaseous stream is heated to a temperature above about 250° C and is then cooled to a temperature of between about 80° C and about 120° C prior to the introduction of the peracetic acid.
16. The method of claim 1 wherein the temperature of the hot gaseous stream is at least about 5° C higher than the dew point of peracetic acid.
17. The method of claim 1 wherein the contact between the peracetic acid vapor and the material to be sterilized is maintained for a period of between about 15 and about 40 minutes.
18. The process of claim 1 wherein the sterilizing composition further comprises one or more additional oxidants selected from the group consisting of chloroperbenzoic acid, perheptanoic acid, peroctanoic acid, perdecanoic acid, performic acid, percitric acid, perglycolic acid, perlactic acid and perbenzoic acid.
19. The process of claim 1 wherein the PAA is in the form of an aqueous equilibrium composition having a PAA:hydrogen peroxide:acetic acid weight ratio selected from the group consisting of 12-18:21-24:5-20; 15: 10:36; 5:23: 10; and 35: 10: 15.
PCT/US2013/030487 2012-03-13 2013-03-12 Improved sterilization method Ceased WO2013138324A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP2015500513A JP6286413B2 (en) 2012-03-13 2013-03-12 Improved sterilization method
AU2013232279A AU2013232279A1 (en) 2012-03-13 2013-03-12 Improved sterilization method
BR112014022845-0A BR112014022845B1 (en) 2012-03-13 2013-03-12 STERILIZATION METHOD
KR1020147028636A KR20150080448A (en) 2012-03-13 2013-03-12 Improved sterilization method
ES13761522.5T ES2662502T3 (en) 2012-03-13 2013-03-12 Enhanced Sterilization Method
MX2014011086A MX358555B (en) 2012-03-13 2013-03-12 Improved sterilization method.
PL13761522T PL2825212T3 (en) 2012-03-13 2013-03-12 Improved sterilization
EP13761522.5A EP2825212B1 (en) 2012-03-13 2013-03-12 Improved sterilization method
CN201380024885.2A CN104284683B (en) 2012-03-13 2013-03-12 Improve method for disinfection
DK13761522.5T DK2825212T3 (en) 2012-03-13 2013-03-12 Improved method of sterilization
AU2015264881A AU2015264881B2 (en) 2012-03-13 2015-12-03 Improved Sterilization Method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610007P 2012-03-13 2012-03-13
US61/610,007 2012-03-13

Publications (2)

Publication Number Publication Date
WO2013138324A2 true WO2013138324A2 (en) 2013-09-19
WO2013138324A3 WO2013138324A3 (en) 2013-11-07

Family

ID=49157826

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/030487 Ceased WO2013138324A2 (en) 2012-03-13 2013-03-12 Improved sterilization method

Country Status (13)

Country Link
US (4) US8865066B2 (en)
EP (1) EP2825212B1 (en)
JP (1) JP6286413B2 (en)
KR (1) KR20150080448A (en)
CN (1) CN104284683B (en)
AU (1) AU2013232279A1 (en)
BR (1) BR112014022845B1 (en)
DK (1) DK2825212T3 (en)
ES (1) ES2662502T3 (en)
MX (1) MX358555B (en)
PL (1) PL2825212T3 (en)
PT (1) PT2825212T (en)
WO (1) WO2013138324A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2719696T3 (en) * 2013-12-20 2019-07-12 Chemische Fabrik Dr Weigert Gmbh & Co Kg Disinfectant agent
US20150305344A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Decontamination or sterilization process
US20190202719A1 (en) * 2016-04-11 2019-07-04 Joseph Daniel Cook Method for controlling mollusk populations
CN106075518B (en) * 2016-07-07 2018-10-16 成都彩虹电器(集团)中南有限公司 A kind of footgear deodorization packet and preparation method thereof
CN110087464B (en) 2016-10-18 2022-04-19 赢创运营有限公司 Soil treatment
CN110248684B (en) * 2017-02-20 2021-07-27 大日本印刷株式会社 Bactericide vaporization device and cleaning method of the bactericide vaporization device
FI3600456T3 (en) 2017-03-27 2023-10-26 Regeneron Pharma Sterilisation method
US11793208B2 (en) 2017-06-15 2023-10-24 Evonik Operations Gmbh Antimicrobial treatment of animal carcasses and food products
CA3082783C (en) 2017-11-20 2023-12-19 Peroxychem Llc Disinfection method for water and wastewater
AU2019222745B2 (en) 2018-02-14 2021-11-04 Evonik Operations Gmbh Treatment of cyanotoxin-containing water
CA3101615A1 (en) 2018-05-31 2019-12-05 Peroxychem Llc Sporicidal methods and compositions
WO2019246512A1 (en) * 2018-06-22 2019-12-26 Peroxychem Llc Sterilization method
CA3127633A1 (en) * 2019-01-28 2020-08-06 Tekdry International, Inc. Sterilization process, system and product including molecular mobility enhancer
EP3886946A1 (en) 2019-06-05 2021-10-06 Regeneron Pharmaceuticals, Inc. Devices and methods for precision dose delivery
KR102353182B1 (en) * 2019-12-13 2022-01-18 이승훈 Percitric acid aqueous solution and method for producing the same
CA3163700A1 (en) * 2020-01-07 2021-07-15 Medivators Inc. Low odor high level disinfectant
KR20230027624A (en) * 2021-08-19 2023-02-28 주식회사 휴온스메디텍 Peracetic acid composition for sterilization or disinfection and method of preparing the same
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0720814A1 (en) 1994-12-14 1996-07-10 Chemoxal Sa Production of disinfecting biocidal formulations based on peracetic ions
US6117457A (en) 1996-12-13 2000-09-12 Chemoxal, S.A. Use of peracetic acid in fish farming
US6596231B1 (en) 1997-12-12 2003-07-22 Tetra Laval Holdings & Finance S.A. Continuous process for hyperactivation of fluids for sterilization
EP1382666A1 (en) 2002-06-21 2004-01-21 Tevan B.V. Aqueous disinfecting compositions with rapid bactericidal effect
WO2008079999A1 (en) 2006-12-22 2008-07-03 Fmc Corporation An improved peracetic acid composition
US20100021558A1 (en) 2008-07-24 2010-01-28 Fmc Corporation Dilute Aqueous Peracid Solutions and Stabilization Method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774912B1 (en) * 1998-02-16 2000-09-01 Sidel Sa METHOD FOR STERILIZING HOLLOW BODIES AND DEVICE FOR IMPLEMENTING SAME
US6534075B1 (en) 1999-03-26 2003-03-18 Ecolab Inc. Antimicrobial and antiviral compositions and treatments for food surfaces
WO2000067805A1 (en) * 1999-05-06 2000-11-16 Intecon Systems, Inc. Cleaning particulate matter and chemical contaminants from hands and elastomeric articles
US6593283B2 (en) 2000-04-28 2003-07-15 Ecolab Inc. Antimicrobial composition
US6544942B1 (en) 2000-04-28 2003-04-08 Ecolab Inc. Phase-separating solvent composition
EP1276372B1 (en) 2000-04-28 2005-10-19 Ecolab Inc. Antimicrobial composition
RU2195319C2 (en) * 2001-01-03 2002-12-27 Смирнов Алексей Владимирович Disinfecting agent
US20050084415A1 (en) * 2001-02-16 2005-04-21 Steris, Inc. High capacity flash vapor generation systems
US6475967B1 (en) 2002-03-05 2002-11-05 Colgate-Palmolive Company Liquid dish cleaning compositions containing a peroxide source
US20030235623A1 (en) * 2002-06-21 2003-12-25 Van Oosterom Piet J.A. Aqueous disinfecting compositions with rapid bactericidal effect
US6962714B2 (en) * 2002-08-06 2005-11-08 Ecolab, Inc. Critical fluid antimicrobial compositions and their use and generation
US7771737B2 (en) 2004-01-09 2010-08-10 Ecolab Inc. Medium chain peroxycarboxylic acid compositions
US9034390B2 (en) * 2006-05-02 2015-05-19 Bioneutral Laboratories Corporation Anti-microbial composition and method for making and using same
DK2391391T3 (en) * 2009-02-02 2019-03-04 Peroxychem Llc Method of sterilization

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0720814A1 (en) 1994-12-14 1996-07-10 Chemoxal Sa Production of disinfecting biocidal formulations based on peracetic ions
US6117457A (en) 1996-12-13 2000-09-12 Chemoxal, S.A. Use of peracetic acid in fish farming
US6596231B1 (en) 1997-12-12 2003-07-22 Tetra Laval Holdings & Finance S.A. Continuous process for hyperactivation of fluids for sterilization
EP1382666A1 (en) 2002-06-21 2004-01-21 Tevan B.V. Aqueous disinfecting compositions with rapid bactericidal effect
WO2008079999A1 (en) 2006-12-22 2008-07-03 Fmc Corporation An improved peracetic acid composition
US20100021558A1 (en) 2008-07-24 2010-01-28 Fmc Corporation Dilute Aqueous Peracid Solutions and Stabilization Method

Also Published As

Publication number Publication date
KR20150080448A (en) 2015-07-09
BR112014022845B1 (en) 2019-10-08
US20180271090A1 (en) 2018-09-27
ES2662502T3 (en) 2018-04-06
WO2013138324A3 (en) 2013-11-07
US20130243650A1 (en) 2013-09-19
US9986737B2 (en) 2018-06-05
US9295744B2 (en) 2016-03-29
AU2013232279A1 (en) 2014-10-30
EP2825212A2 (en) 2015-01-21
US8865066B2 (en) 2014-10-21
PT2825212T (en) 2018-03-14
MX358555B (en) 2018-08-24
EP2825212B1 (en) 2018-01-03
CN104284683B (en) 2018-02-23
MX2014011086A (en) 2015-03-05
JP2015509985A (en) 2015-04-02
JP6286413B2 (en) 2018-02-28
PL2825212T3 (en) 2018-06-29
CN104284683A (en) 2015-01-14
EP2825212A4 (en) 2015-07-01
DK2825212T3 (en) 2018-03-26
US20150037209A1 (en) 2015-02-05
US20160183522A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
US8865066B2 (en) Sterilization method
EP2391391B1 (en) Sterilization method
KR100317577B1 (en) Composition and uses thereof
EP2665496B1 (en) Peracetic acid vapor sterilization preferably of food and beverage containers
WO2019246512A1 (en) Sterilization method
AU2015264881B2 (en) Improved Sterilization Method
CN101032254A (en) H2O2 air disinfectant with high stability
CN108348626B (en) Aqueous hydrogen peroxide solution comprising specific stabilizer
RU2745120C2 (en) Disinfectant agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13761522

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: MX/A/2014/011086

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2015500513

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2013761522

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20147028636

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112014022845

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2013232279

Country of ref document: AU

Date of ref document: 20130312

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112014022845

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20140915